...
首页> 外文期刊>Biotechnology Letters >Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway
【24h】

Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway

机译:黄素激动素B通过Bax启动的线粒体和JNK途径诱导非小细胞肺癌H460细胞凋亡

获取原文
获取原文并翻译 | 示例
           

摘要

Flavokawain B (FKB) possesses strong anti-neoplastic activity against many cancer cells. Here we assessed its antitumor activity and molecular mechanisms in lung cancer H460 cells in vitro. FKB significantly inhibited cell proliferation and caused arrest of the cell cycle G2-M of H460 cells in a dose-dependent manner. FKB also inducted apoptosis,which was associated with cytochrome c release, caspase-7 and caspase-9 activation and Bcl-xL/Bax dys-regulation. FKB significantly down-regulated survivin and XIAP, and the inhibitory effect induced by FKB was greatly attenuated by through over-expression of survivin or Bax~(-/-) MEFs. Furthermore, FKB activated the mitogen-activated protein kinases and the JNK inhibitor SP600125 significantly decreased thegrowth-inhibitory and apoptotic effects of FKB. Together, these results suggest the anti-lung cancer potential of flavokawain B for the prevention and treatment of lung cancer.
机译:Flavokawain B(FKB)对许多癌细胞具有很强的抗肿瘤活性。在这里,我们评估了其在肺癌H460细胞中的抗肿瘤活性和分子机制。 FKB以剂量依赖性方式显着抑制H460细胞的细胞增殖并引起细胞周期G2-M的停滞。 FKB还诱导细胞凋亡,这与细胞色素c释放,caspase-7和caspase-9活化以及Bcl-xL / Bax失调有关。 FKB显着下调了survivin和XIAP,而FKB诱导的抑制作用由于survivin或Bax〜(-/-)MEF的过度表达而大大减弱。此外,FKB激活了促分裂原活化的蛋白激酶,JNK抑制剂SP600125显着降低了FKB的生长抑制和凋亡作用。总之,这些结果表明黄酮类固醇B具有预防和治疗肺癌的潜在肺癌作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号